150 related articles for article (PubMed ID: 26203049)
1. Increased cathepsin D protein expression is a biomarker for osteosarcomas, pulmonary metastases and other bone malignancies.
Gemoll T; Epping F; Heinrich L; Fritzsche B; Roblick UJ; Szymczak S; Hartwig S; Depping R; Bruch HP; Thorns C; Lehr S; Paech A; Habermann JK
Oncotarget; 2015 Jun; 6(18):16517-26. PubMed ID: 26203049
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of chemonaive pediatric osteosarcomas and corresponding normal bone reveals multiple altered molecular targets.
Folio C; Mora MI; Zalacain M; Corrales FJ; Segura V; Sierrasesúmaga L; Toledo G; San-Julián M; Patiño-García A
J Proteome Res; 2009 Aug; 8(8):3882-8. PubMed ID: 19492781
[TBL] [Abstract][Full Text] [Related]
4. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
[TBL] [Abstract][Full Text] [Related]
5. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis.
Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ
J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155
[TBL] [Abstract][Full Text] [Related]
6. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.
Shen J; Person MD; Zhu J; Abbruzzese JL; Li D
Cancer Res; 2004 Dec; 64(24):9018-26. PubMed ID: 15604267
[TBL] [Abstract][Full Text] [Related]
7. HACE1 is a potential tumor suppressor in osteosarcoma.
El-Naggar AM; Clarkson PW; Negri GL; Turgu B; Zhang F; Anglesio MS; Sorensen PH
Cell Death Dis; 2019 Jan; 10(1):21. PubMed ID: 30622235
[TBL] [Abstract][Full Text] [Related]
8. [Cell proliferation in bone tumors. Immunohistologic study of Ki-67 protein expression].
Stenzel I; Pösl M; Ritzel H; Hentz M; Werner M; Delling G
Pathologe; 1996 Jan; 17(1):56-62. PubMed ID: 8685097
[TBL] [Abstract][Full Text] [Related]
9. Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine.
Subbiah V; Wagner MJ; McGuire MF; Sarwari NM; Devarajan E; Lewis VO; Westin S; Kato S; Brown RE; Anderson P
Oncotarget; 2015 Dec; 6(38):40642-54. PubMed ID: 26510912
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin D is secreted from M-BE cells: its potential role as a biomarker of lung cancer.
Lou X; Xiao T; Zhao K; Wang H; Zheng H; Lin D; Lu Y; Gao Y; Cheng S; Liu S; Xu N
J Proteome Res; 2007 Mar; 6(3):1083-92. PubMed ID: 17284061
[TBL] [Abstract][Full Text] [Related]
11. A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung.
Benjamin R; Helman L; Meyers P; Reaman G
Hum Gene Ther; 2001 Aug; 12(12):1591-3. PubMed ID: 11529247
[TBL] [Abstract][Full Text] [Related]
12. Plasma membrane proteomic analysis of human osteosarcoma and osteoblastic cells: revealing NDRG1 as a marker for osteosarcoma.
Hua Y; Jia X; Sun M; Zheng L; Yin L; Zhang L; Cai Z
Tumour Biol; 2011 Oct; 32(5):1013-21. PubMed ID: 21706236
[TBL] [Abstract][Full Text] [Related]
13. Proteomic approach toward molecular backgrounds of drug resistance of osteosarcoma cells in spheroid culture system.
Arai K; Sakamoto R; Kubota D; Kondo T
Proteomics; 2013 Aug; 13(15):2351-60. PubMed ID: 23712969
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of bone morphogenetic activity in osteosarcoma tissue.
Yoshikawa H; Takaoka K; Masuhara K; Ono K; Sakamoto Y
Cancer; 1988 Feb; 61(3):569-73. PubMed ID: 3422172
[TBL] [Abstract][Full Text] [Related]
15. 2-DE analysis of breast cancer cell lines 1833 and 4175 with distinct metastatic organ-specific potentials: comparison with parental cell line MDA-MB-231.
Selicharova I; Sanda M; Mladkova J; Ohri SS; Vashishta A; Fusek M; Jiracek J; Vetvicka V
Oncol Rep; 2008 May; 19(5):1237-44. PubMed ID: 18425382
[TBL] [Abstract][Full Text] [Related]
16. Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1.
Rivera J; Megias D; Bravo J
J Proteome Res; 2007 Oct; 6(10):4006-18. PubMed ID: 17854218
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of nucleoside diphosphate kinase/nm23 and c-Ha-ras mRNA is associated with spontaneous lung metastasis in rat-transplantable osteosarcomas.
Honoki K; Tsutsumi M; Miyauchi Y; Mii Y; Tsujiuchi T; Morishita T; Miura S; Aoki M; Kobayashi E; Tamai S
Cancer Res; 1993 Oct; 53(20):5038-42. PubMed ID: 8402697
[TBL] [Abstract][Full Text] [Related]
18. Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.
Brown LM; Helmke SM; Hunsucker SW; Netea-Maier RT; Chiang SA; Heinz DE; Shroyer KR; Duncan MW; Haugen BR
Mol Carcinog; 2006 Aug; 45(8):613-26. PubMed ID: 16788983
[TBL] [Abstract][Full Text] [Related]
19. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
[TBL] [Abstract][Full Text] [Related]
20. The metastatic behavior of osteosarcoma by gene expression and cytogenetic analyses.
Salinas-Souza C; De Oliveira R; Alves MT; Garcia Filho RJ; Petrilli AS; Toledo SR
Hum Pathol; 2013 Oct; 44(10):2188-98. PubMed ID: 23845465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
